文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

基于我国肺炎球菌血清型分布特征的肺炎球菌结合疫苗研发进展

[Research and development progress of pneumococcal conjugate vaccines based on the serotype distribution characteristics of pneumococci in China].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2026-01-01

肺炎球菌性疾病是全球重要公共卫生负担,在<5岁儿童及老年人群中尤为突出,已鉴定出100多种血清型。本文系统梳理我国肺炎球菌血清型分布与耐药现状,总结PCV免疫保护机制,比较不同价次PCV的免疫原性与保护作用,并讨论高价次及通用型疫苗研发方向,为我国PCV血清型覆盖设计与免疫策略优化提供证据参考。

要点

  • 我国肺炎球菌血清型谱随疫苗推广呈动态变化,需持续积累流行病学与真实世界证据。
  • 荚膜多糖介导的免疫逃逸与血清型相关,多价覆盖对疾病防控有重要公共卫生意义。
  • 高价次PCV及通用型肺炎球菌疫苗是研发方向,需明确关键科学问题。

核心结论

  • 我国肺炎球菌血清型分布随疫苗应用动态变化,需以血清型流行病学与真实世界证据支持PCV血清型覆盖设计和免疫策略优化。

研究设计与样本

  • 本文为综述,系统梳理我国肺炎球菌血清型及相关疾病分布特征与耐药现状,并比较不同价次PCV的免疫原性与保护作用。

主要发现

  • 目前已鉴定出100多种肺炎球菌血清型,其致病性与血清型特异性荚膜多糖介导的免疫逃逸相关。
  • 肺炎球菌性疾病在<5岁儿童及老年人群中负担更为突出。
  • 随着肺炎球菌疫苗在我国推广应用,血清型谱呈动态变化,相关流行病学与疫苗真实世界证据持续积累。

临床怎么用

  • 可为我国PCV血清型覆盖设计与免疫策略优化提供证据参考和科学支撑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Streptococcus pneumoniae (Spn) is one of the major pathogens responsible for morbidity and mortality worldwide, and pneumococcal diseases constitute a significant global public health burden, with a particularly high burden among children under five years of age and older adults. Based on differences in the structure of capsular polysaccharides, more than 100 pneumococcal serotypes have been identified to date. The pathogenicity of Spn is, to some extent, associated with immune evasion mediated by serotype-specific capsular polysaccharides; therefore, pneumococcal vaccines covering multiple serotypes have significant public health importance for the prevention and control of related diseases. With the promotion and application of pneumococcal vaccines in China, the serotype distribution of Spn has undergone dynamic changes, and serotype-specific epidemiological evidence as well as real-world evidence on vaccine use has continued to accumulate. This study systematically reviews the distribution characteristics of Spn serotypes and related diseases in China, as well as the current status of antimicrobial resistance; describes the immune protective mechanisms of pneumococcal conjugate vaccines (PCVs) against different serotypes; compares the immunogenicity and protective effects of PCVs with different valences; and discusses the development directions and key scientific issues of higher-valent PCVs and universal pneumococcal vaccines, in order to provide evidence reference and scientific support for the design of PCV serotype coverage and the optimization of immunization strategies in China. 肺炎球菌(Spn)是全球范围内导致人群发病与死亡的重要病原体之一,其所致的肺炎球菌性疾病构成全球重要公共卫生负担,在<5岁儿童及老年人群中负担更为突出。根据荚膜多糖结构差异,目前已鉴定出100多种肺炎球菌血清型。Spn的致病性在一定程度上与血清型特异性荚膜多糖介导的免疫逃逸相关,因此,覆盖多种血清型的肺炎球菌疫苗对相关疾病防控具有重要公共卫生意义。随着肺炎球菌疫苗在我国推广应用,Spn血清型谱呈动态变化,血清型相关流行病学证据及疫苗真实世界证据也在持续积累。本研究系统梳理了我国Spn血清型及相关疾病的分布特征与耐药现状,总结肺炎球菌结合疫苗(PCV)对不同血清型的免疫保护机制,比较不同价次PCV的免疫原性与保护作用,并讨论高价次PCV及通用型肺炎球菌疫苗研发的方向与关键科学问题,以期为我国PCV血清型覆盖设计与免疫策略优化提供证据参考和科学支撑。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Fan CL, Zheng H, Zeng M, et al. [Research and development progress of pneumococcal conjugate vaccines based on the serotype distribution characteristics of pneumococci in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2026. PMID: 42100913. doi:10.3760/cma.j.cn112150-20250805-00756-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。